Conmed Corp (CNMD) is now in the Undervalued zone, suggesting that its current forward PE ratio of 9.24 is considered Undervalued compared with the five-year average of 25.90. The fair price of Conmed Corp (CNMD) is between 96.76 to 185.19 according to relative valuation method. Compared to the current price of 45.79 USD , Conmed Corp By Undervalued By 52.68%.

Relative Value

Fair Zone

96.76-185.19

Current Price：45.79

52.68%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Conmed Corp (CNMD) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Conmed Corp (CNMD) has a current Price-to-Book (P/B) ratio of 1.24. Compared to its 3-year average P/B ratio of 2.84, the current P/B ratio is approximately -56.18% higher. Relative to its 5-year average P/B ratio of 3.63, the current P/B ratio is about -65.74% higher. Conmed Corp (CNMD) has a Forward Free Cash Flow (FCF) yield of approximately 11.87%. Compared to its 3-year average FCF yield of 5.66%, the current FCF yield is approximately 109.73% lower. Relative to its 5-year average FCF yield of 4.14%, the current FCF yield is about 186.71% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for CNMD competitors is 5.90, providing a benchmark for relative valuation. Conmed Corp Corp (CNMD.N) exhibits a P/S ratio of 0.90, which is -84.68% above the industry average. Given its robust revenue growth of 7.88%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of CNMD increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of CNMD in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is CNMD currently overvalued or undervalued?

What is Conmed Corp (CNMD) fair value?

CNMD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Conmed Corp (CNMD) is between 96.76 to 185.19 according to relative valuation method.

How does CNMD's valuation metrics compare to the industry average?

The average P/S ratio for CNMD's competitors is 5.90, providing a benchmark for relative valuation. Conmed Corp Corp (CNMD) exhibits a P/S ratio of 0.90, which is -84.68% above the industry average. Given its robust revenue growth of 7.88%, this premium appears unsustainable.

What is the current P/B ratio for Conmed Corp (CNMD) as of Mar 02 2026?

As of Mar 02 2026, Conmed Corp (CNMD) has a P/B ratio of 1.24. This indicates that the market values CNMD at 1.24 times its book value.

What is the current FCF Yield for Conmed Corp (CNMD) as of Mar 02 2026?

As of Mar 02 2026, Conmed Corp (CNMD) has a FCF Yield of 11.87%. This means that for every dollar of Conmed Corp's market capitalization, the company generates 11.87 cents in free cash flow.

What is the current Forward P/E ratio for Conmed Corp (CNMD) as of Mar 02 2026?

As of Mar 02 2026, Conmed Corp (CNMD) has a Forward P/E ratio of 9.24. This means the market is willing to pay $9.24 for every dollar of Conmed Corp's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Conmed Corp (CNMD) as of Mar 02 2026?

As of Mar 02 2026, Conmed Corp (CNMD) has a Forward P/S ratio of 0.90. This means the market is valuing CNMD at $0.90 for every dollar of expected revenue over the next 12 months.

CNMD Valuation